目的：分析我院对原发性急性闭角型青光眼患者实施临床路径前后2a的临床资料，评估临床路径在原发性急性闭角型青光眼患者中的实施价值。 方法：以我院2010-01/2011-12因原发性急性闭角型青光眼在我院行滤过手术（小梁切除术或复合式小梁切除术）进入临床路径的82例83眼为路径组，以2008-01/2009-12因同样疾病治疗未采用临床路径的67例68眼为对照组。分析两组患者平均住院日、术前平均住院日、平均住院费用、治愈率、患者满意度指标。 结果：路径组平均住院日7.0d，术前平均住院日2.6d，平均住院费用2 158元，满意度97.4%；对照组平均住院日11.2d，术前平均住院日4.2d，平均住院费用2 630元，满意度90.2%，两组比较差异有统计学意义（P＜0.05）。路径组治愈率为95.2%，对照组治愈率为94.1%，两组比较差异无统计学意义（P＞0.05）。 结论：原发性急性闭角型青光眼患者实施临床路径不会降低医疗质量；相反可以缩短患者平均住院日、术前平均住院日、降低患者平均住院费用、提高患者满意度。

AIM:To analyze the outcome of clinical pathways for patients with primary acute angle-closure glaucoma in our hospital for two years and evaluate the value of this way. METHODS:Eighty-three eyes of 82 patients who suffered primary acute angle-closure glaucoma from January 2010 to December 2011 were cured with filtering operation (trabeculectomy or composite trabeculectomy) by managing with clinical path, they are divided path group. The control group was another 67 patients from January 2008 to December 2009, who suffered the same disease and cured with the same operation not by managing with clinical path. The working days before surgery, days in hospital, cost for cure, curative effect, and degree of satisfaction of patients were all recorded for analysis. RESULTS:The path group had an average of 2.6 working days before surgery, 7.0 days in hospital, cost of 2158 yuan for cure, degree of satisfaction of patients(974%). The control group had an average of 4.2 working days before surgery, 11.2 days in hospital, cost of 2630 yuan for cure, degree of satisfaction of patients(90.2%). They were all statistically different(P＜0.05), but there was no difference in curative effect(P>0.05). CONCLUSION: The clinical path for patients with primary acute angle-closure glaucoma can not only shorten working days before surgery and days in hospital, but also save cost for cure and improve the degree of satisfaction of patients.